Hyponatremia and Hepatorenal Syndrome - Wikidata - wikimedia - TriplyDB

Hyponatremia and Hepatorenal Syndrome

Hyponatremia and Hepatorenal Syndrome

http://www.wikidata.org/entity/Q36812531

about

Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation.

P2860

Q41775845-3C289B18-294F-49B9-89D0-FC0197BDCA8E

P2860

Hyponatremia and Hepatorenal Syndrome

http://www.wikidata.org/entity/Q36812531

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Hyponatremia and Hepatorenal Syndrome

@ast

Hyponatremia and Hepatorenal Syndrome

@en

type

label

Hyponatremia and Hepatorenal Syndrome

@ast

Hyponatremia and Hepatorenal Syndrome

@en

prefLabel

Hyponatremia and Hepatorenal Syndrome

@ast

Hyponatremia and Hepatorenal Syndrome

@en

P1433

Q36812531-B90FD0AA-F55B-4AAC-AFC8-03D1F29155C2

P1476

Q36812531-B831BCAC-DDE6-4755-91CB-D9C88107E246

P2093

Q36812531-36A7F0BE-62D4-4E8C-AE4E-930E3D3F9D20

Q36812531-47A17ED9-53DA-405A-98C3-44A2FAD7FD07

P2860

Q36812531-071FAD15-2AEF-46EC-BDE5-D9A871B6F788

Q36812531-0DEC514F-6A55-49CF-A74F-B2A6256DCD85

Q36812531-0E4B6CE1-4E9D-4BAF-8198-3BB76E2092DF

Q36812531-1512801E-6176-45B9-AA4E-2037C5BCCA25

Q36812531-151DFDD9-F00F-4354-84DB-B3FA7020890E

Q36812531-165293EA-B430-46B6-BAD6-8EB534840EE6

Q36812531-16CB4F29-E72B-4554-BE6C-F846880DBC03

Q36812531-1BCDF40F-7205-43A8-A99B-723F8B253235

Q36812531-1BD7EB7C-3582-4D27-B689-06D3CB706E0A

Q36812531-1CB8805F-97CC-4A75-B217-BFBF52A529F7

P304

Q36812531-4C8A2D41-2016-4E42-ACBD-2EC1D845BD8D

P31

Q36812531-D3B79335-EDCF-4A9F-8B53-DBDFBE16C767

P433

Q36812531-4EB76174-2546-4704-856D-C095D1EE1A0D

P478

Q36812531-26457DD4-D10A-4B9A-9C25-A29B08E00B67

P577

Q36812531-F670F453-67FD-4FD8-B432-6F790D69048B

P698

Q36812531-75FEBE3B-5ABB-40CA-9DA5-5314284A93F1

P932

Q36812531-BBCC1848-CAF8-47BC-9FEA-6109DBB04DC2

P1433

Gastroenterology & hepatology

P1476

Hyponatremia and Hepatorenal Syndrome

@en

P2093

Arpan Mohanty

http://www.w3.org/2001/XMLSchema#string

Guadalupe Garcia-Tsao

http://www.w3.org/2001/XMLSchema#string

P2860

Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury

Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Correction of hyponatraemia improves cognition, quality of life, and brain oedema in cirrhosis.

Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.

Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury.

Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures.

Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide.

Long-term therapy and retreatment of hepatorenal syndrome type 1 with ornipressin and dopamine.

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

P304

220-229

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27099594

http://www.w3.org/2001/XMLSchema#string

P932

4836593

http://www.w3.org/2001/XMLSchema#string